BioAtla, Inc. (BCAB) Tops Q2 EPS by 1c

BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.44), $0.01 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Google execs convened 'all-hands' meeting last week to address AI unit reorganizations amid staff concerns - Reuters
• Uber may launch ride service for children as young as 10
• Barclays sees upside for Alibaba, Churchill Downs